Definitive Contract 75F40123C00071
- Not listed
- This is a $190,800 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is for knowledge management services. Caitta Inc. specializes in providing scientific, technical, and administrative services to federal health and research agencies, with expertise in supplying sophisticated scientific and...
- This is a $442,329.37 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is for drug shortage support services for the FDA's Office of Generic Drugs. The contract has an ultimate completion date of May 31, 2020 and was awarded on May 29, 2015. Caitta Inc. is a federal contractor that specializes in providing scientific,...
- This is a $149,470.00 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The contract is not set aside. The purpose of this effort is to integrate compliance within an existing quality management system (QMS) for regulating pharmaceutical quality. The contract does not involve information technology/systems development. Caitta Inc....
- This firm-fixed-price delivery order contract was awarded to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), by the Food and Drug Administration (FDA) for regulatory health project management services. The contract has a ceiling value of $372,662.98 and an ultimate completion date of July 3, 2021. Caitta Inc. is a key supplier to federal agencies like the Department of Health and Human Services (HHS), FDA, National Institutes of Health (NIH), and...
- The Department of Health and Human Services Food and Drug Administration awarded a $217,346.52 firm fixed price purchase order to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The award is for contractor support services, with a performance period ending on May 3, 2023. Caitta has a history of providing scientific, technical, and administrative services to HHS and its agencies, including the FDA, NIH, and NIST, through both competitive awards and...
- This is a firm fixed price delivery order awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The $524,377.60 contract is for the services of a senior subject matter expert, with a completion date of June 21, 2020. Caitta is an experienced contractor providing scientific, technical, and administrative services to federal agencies in the public health domain....
- This is a firm fixed price contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Caitta Inc., an SBA certified 8(a) economically disadvantaged woman-owned small business. The contract is for the FDA's Center for Drug Evaluation and Research (CDER) Office of Compliance (OC) Compounding Program Business Process Improvement (BPI) and Quality Management System, with a completion date of August 15, 2024 and a potential value of $881,893.55. Caitta...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB). The $1,092,204.46 contract is for the delivery of two mass spectrometers, with a completion date of September 22, 2027. Caitta Inc. is a strategic federal contractor focused on providing scientific instrumentation, analytical equipment, and professional services to...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB). The contract is for $1,518,064.70 and has an ultimate completion date of July 24, 2028. The contract is for a "Small Dispensers Assessment and Business Process Improvement (BPI) to Establish a Quality Management System (QMS)." Caitta Inc. is a strategic federal...
- Caitta Inc. was awarded a $514,325 definitive contract by the Department of Health and Human Services' Food and Drug Administration (HHS FDA) to retain expert witness services for both compounding and non-compounding related injunctions. The contract has an 8(a) sole source set aside designation for Caitta as an SBA-certified economically disadvantaged woman-owned small business. Work will be performed in Herndon, Virginia through September 2023 and utilizes a labor hours pricing structure. This...
This is a $2,485,367.54 definitive contract awarded to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant, by the Food and Drug Administration (FDA). The contract is for expert services related to SharePoint, expert witnesses, and data integrity. It is an 8(a) sole source contract with a period of performance through April 4, 2025. Caitta Inc. specializes in providing scientific, technical, and administrative services to federal health and research agencies, including procuring high-end analytical instruments and delivering specialized support services. This contract adds to Caitta's existing federal contract vehicles, including a $2 million Federal Supply Schedule contract with the General Services Administration (GSA) and a $999,000 multiple-award contract with the FDA for portable mass spectrometry systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Terminate for Convenience | $0 | 4/4/25 | |
| P00003 | Other Administrative Action | $0 | 3/28/25 | |
| P00002 | Supplemental Agreement for work within scope | $1.1m | 7/22/24 | |
| P00001 | Supplemental Agreement for work within scope | $19.7k | 6/25/24 | |
| Not listed | Not listed | $300.7k | 6/20/23 |